Bioorganic and Medicinal Chemistry Letters p. 4552 - 4557 (2017)
Update date:2022-08-25
Topics:
Jain, Akanksha
Kameswaran, Mythili
Pandey, Usha
Prabhash, Kumar
Sarma, Haladhar Dev
Dash, Ashutosh
Molecular imaging using radiolabeled Tyrosine Kinase Inhibitors (TKI) is a promising strategy for detection and staging of EGFR-positive cancers. A novel analogue of one such TKI, Erlotinib has been developed for PET imaging by derivatizing the parent Erl
View MoreLianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Contact:+86-512-56795332
Address:No227 Shuanglong Rd, Fenghuang, Zhangjiagang
Guangzhou Reachin Chemical Co., Ltd
Contact:+86-20-37087379 ext.604
Address:A122C-1, Tianyuan Plaza, 401 Tianyuan Rd., Tianhe, Guangzhou, China
Doi:10.1016/j.jphotochem.2015.10.010
(2016)Doi:10.1016/S0040-4039(98)01548-2
(1998)Doi:10.1139/V08-161
(2008)Doi:10.1039/j39700000327
(1970)Doi:10.1007/BF01566046
(1986)Doi:10.1039/d0dt01764g
(2020)